Increased HIV-1 transcriptional activity and infectious burden in peripheral blood and gut-associated CD4+ T cells expressing CD30.
HIV-1-infected cells persist indefinitely despite the use of combination antiretroviral therapy (ART), and novel therapeutic strategies to target and purge residual infected cells in individuals on ART are urgently needed. Here, we demonstrate that CD4+ T cell-associated HIV-1 RNA is often highly en...
Guardado en:
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5f48aaf0ac6f4de885d57506c67f973f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:5f48aaf0ac6f4de885d57506c67f973f |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:5f48aaf0ac6f4de885d57506c67f973f2021-12-02T19:59:40ZIncreased HIV-1 transcriptional activity and infectious burden in peripheral blood and gut-associated CD4+ T cells expressing CD30.1553-73661553-737410.1371/journal.ppat.1006856https://doaj.org/article/5f48aaf0ac6f4de885d57506c67f973f2018-02-01T00:00:00Zhttps://doi.org/10.1371/journal.ppat.1006856https://doaj.org/toc/1553-7366https://doaj.org/toc/1553-7374HIV-1-infected cells persist indefinitely despite the use of combination antiretroviral therapy (ART), and novel therapeutic strategies to target and purge residual infected cells in individuals on ART are urgently needed. Here, we demonstrate that CD4+ T cell-associated HIV-1 RNA is often highly enriched in cells expressing CD30, and that cells expressing this marker considerably contribute to the total pool of transcriptionally active CD4+ lymphocytes in individuals on suppressive ART. Using in situ RNA hybridization studies, we show co-localization of CD30 with HIV-1 transcriptional activity in gut-associated lymphoid tissues. We also demonstrate that ex vivo treatment with brentuximab vedotin, an antibody-drug conjugate (ADC) that targets CD30, significantly reduces the total amount of HIV-1 DNA in peripheral blood mononuclear cells obtained from infected, ART-suppressed individuals. Finally, we observed that an HIV-1-infected individual, who received repeated brentuximab vedotin infusions for lymphoma, had no detectable virus in peripheral blood mononuclear cells. Overall, CD30 may be a marker of residual, transcriptionally active HIV-1 infected cells in the setting of suppressive ART. Given that CD30 is only expressed on a small number of total mononuclear cells, it is a potential therapeutic target of persistent HIV-1 infection.Louise E HoganJoshua VasquezKristen S HobbsEmily HanhauserBrandon Aguilar-RodriguezRajaa HussienCassandra ThanhErica A GibsonAlexander B CarvidiLouis C B SmithShahzada KhanMartin TrapecarShomyseh SanjabiMa SomsoukCheryl A StoddartDaniel R KuritzkesSteven G DeeksTimothy J HenrichPublic Library of Science (PLoS)articleImmunologic diseases. AllergyRC581-607Biology (General)QH301-705.5ENPLoS Pathogens, Vol 14, Iss 2, p e1006856 (2018) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Immunologic diseases. Allergy RC581-607 Biology (General) QH301-705.5 |
spellingShingle |
Immunologic diseases. Allergy RC581-607 Biology (General) QH301-705.5 Louise E Hogan Joshua Vasquez Kristen S Hobbs Emily Hanhauser Brandon Aguilar-Rodriguez Rajaa Hussien Cassandra Thanh Erica A Gibson Alexander B Carvidi Louis C B Smith Shahzada Khan Martin Trapecar Shomyseh Sanjabi Ma Somsouk Cheryl A Stoddart Daniel R Kuritzkes Steven G Deeks Timothy J Henrich Increased HIV-1 transcriptional activity and infectious burden in peripheral blood and gut-associated CD4+ T cells expressing CD30. |
description |
HIV-1-infected cells persist indefinitely despite the use of combination antiretroviral therapy (ART), and novel therapeutic strategies to target and purge residual infected cells in individuals on ART are urgently needed. Here, we demonstrate that CD4+ T cell-associated HIV-1 RNA is often highly enriched in cells expressing CD30, and that cells expressing this marker considerably contribute to the total pool of transcriptionally active CD4+ lymphocytes in individuals on suppressive ART. Using in situ RNA hybridization studies, we show co-localization of CD30 with HIV-1 transcriptional activity in gut-associated lymphoid tissues. We also demonstrate that ex vivo treatment with brentuximab vedotin, an antibody-drug conjugate (ADC) that targets CD30, significantly reduces the total amount of HIV-1 DNA in peripheral blood mononuclear cells obtained from infected, ART-suppressed individuals. Finally, we observed that an HIV-1-infected individual, who received repeated brentuximab vedotin infusions for lymphoma, had no detectable virus in peripheral blood mononuclear cells. Overall, CD30 may be a marker of residual, transcriptionally active HIV-1 infected cells in the setting of suppressive ART. Given that CD30 is only expressed on a small number of total mononuclear cells, it is a potential therapeutic target of persistent HIV-1 infection. |
format |
article |
author |
Louise E Hogan Joshua Vasquez Kristen S Hobbs Emily Hanhauser Brandon Aguilar-Rodriguez Rajaa Hussien Cassandra Thanh Erica A Gibson Alexander B Carvidi Louis C B Smith Shahzada Khan Martin Trapecar Shomyseh Sanjabi Ma Somsouk Cheryl A Stoddart Daniel R Kuritzkes Steven G Deeks Timothy J Henrich |
author_facet |
Louise E Hogan Joshua Vasquez Kristen S Hobbs Emily Hanhauser Brandon Aguilar-Rodriguez Rajaa Hussien Cassandra Thanh Erica A Gibson Alexander B Carvidi Louis C B Smith Shahzada Khan Martin Trapecar Shomyseh Sanjabi Ma Somsouk Cheryl A Stoddart Daniel R Kuritzkes Steven G Deeks Timothy J Henrich |
author_sort |
Louise E Hogan |
title |
Increased HIV-1 transcriptional activity and infectious burden in peripheral blood and gut-associated CD4+ T cells expressing CD30. |
title_short |
Increased HIV-1 transcriptional activity and infectious burden in peripheral blood and gut-associated CD4+ T cells expressing CD30. |
title_full |
Increased HIV-1 transcriptional activity and infectious burden in peripheral blood and gut-associated CD4+ T cells expressing CD30. |
title_fullStr |
Increased HIV-1 transcriptional activity and infectious burden in peripheral blood and gut-associated CD4+ T cells expressing CD30. |
title_full_unstemmed |
Increased HIV-1 transcriptional activity and infectious burden in peripheral blood and gut-associated CD4+ T cells expressing CD30. |
title_sort |
increased hiv-1 transcriptional activity and infectious burden in peripheral blood and gut-associated cd4+ t cells expressing cd30. |
publisher |
Public Library of Science (PLoS) |
publishDate |
2018 |
url |
https://doaj.org/article/5f48aaf0ac6f4de885d57506c67f973f |
work_keys_str_mv |
AT louiseehogan increasedhiv1transcriptionalactivityandinfectiousburdeninperipheralbloodandgutassociatedcd4tcellsexpressingcd30 AT joshuavasquez increasedhiv1transcriptionalactivityandinfectiousburdeninperipheralbloodandgutassociatedcd4tcellsexpressingcd30 AT kristenshobbs increasedhiv1transcriptionalactivityandinfectiousburdeninperipheralbloodandgutassociatedcd4tcellsexpressingcd30 AT emilyhanhauser increasedhiv1transcriptionalactivityandinfectiousburdeninperipheralbloodandgutassociatedcd4tcellsexpressingcd30 AT brandonaguilarrodriguez increasedhiv1transcriptionalactivityandinfectiousburdeninperipheralbloodandgutassociatedcd4tcellsexpressingcd30 AT rajaahussien increasedhiv1transcriptionalactivityandinfectiousburdeninperipheralbloodandgutassociatedcd4tcellsexpressingcd30 AT cassandrathanh increasedhiv1transcriptionalactivityandinfectiousburdeninperipheralbloodandgutassociatedcd4tcellsexpressingcd30 AT ericaagibson increasedhiv1transcriptionalactivityandinfectiousburdeninperipheralbloodandgutassociatedcd4tcellsexpressingcd30 AT alexanderbcarvidi increasedhiv1transcriptionalactivityandinfectiousburdeninperipheralbloodandgutassociatedcd4tcellsexpressingcd30 AT louiscbsmith increasedhiv1transcriptionalactivityandinfectiousburdeninperipheralbloodandgutassociatedcd4tcellsexpressingcd30 AT shahzadakhan increasedhiv1transcriptionalactivityandinfectiousburdeninperipheralbloodandgutassociatedcd4tcellsexpressingcd30 AT martintrapecar increasedhiv1transcriptionalactivityandinfectiousburdeninperipheralbloodandgutassociatedcd4tcellsexpressingcd30 AT shomysehsanjabi increasedhiv1transcriptionalactivityandinfectiousburdeninperipheralbloodandgutassociatedcd4tcellsexpressingcd30 AT masomsouk increasedhiv1transcriptionalactivityandinfectiousburdeninperipheralbloodandgutassociatedcd4tcellsexpressingcd30 AT cherylastoddart increasedhiv1transcriptionalactivityandinfectiousburdeninperipheralbloodandgutassociatedcd4tcellsexpressingcd30 AT danielrkuritzkes increasedhiv1transcriptionalactivityandinfectiousburdeninperipheralbloodandgutassociatedcd4tcellsexpressingcd30 AT stevengdeeks increasedhiv1transcriptionalactivityandinfectiousburdeninperipheralbloodandgutassociatedcd4tcellsexpressingcd30 AT timothyjhenrich increasedhiv1transcriptionalactivityandinfectiousburdeninperipheralbloodandgutassociatedcd4tcellsexpressingcd30 |
_version_ |
1718375724215173120 |